IMEXPHARM CORPORATION
Last · HOSEVND 36600.000.00 (0.00%)live · yahoo · 5h ago
Vol 758 ≈ 27.74M
MA10MA20MA50
Market capVND 5.64T154.0M sh
P/E · TTM85.3fwd — · eps 429.02
Beta0.43vs S&P 500
Div yield1.62%annual · TTM
52w range
VND 32650.00VND 57000.00
Volume758session
Issuer
Legal nameIMEXPHARM CORPORATION
HQVietnam (VN)
ListingVN IMP
ISINVN000000IMP0
SectorHealthcare
IndustryPharmaceuticals
CurrencyVND
Entity registryisin:VN000000IMP0
Org IDIMP
Websitewww.imexpharm.com
| Revenue | VND 562.2B |
|---|---|
| Operating income | VND 117.9B |
| Net income | VND 93.9B |
| Operating margin | 21.0% |
| Net margin | 16.7% |
| Return on equity | 4.0% |
| Period | 2026 |
Loading chart…
Earnings transcripts
- Issuer webcastVideo
Annual Results FY2025
IMPALA PLATINUM HOLDINGS LIMITED
- Issuer webcastVideo
Annual Results FY2025
IMPALA PLATINUM HOLDINGS LIMITED
- Issuer webcastVideo
video
IMPALA PLATINUM HOLDINGS LIMITED
- Issuer webcastVideo
Implats Interim Results
IMPALA PLATINUM HOLDINGS LIMITED
- Issuer webcastVideo
Annual Results FY2025
IMPALA PLATINUM HOLDINGS LIMITED
- Issuer webcastVideo
Implats annual results 2024
IMPALA PLATINUM HOLDINGS LIMITED
Documents
FormReporting forFiledFlags
Showing 5 of 150 filings